ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.121,10
0,71%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07715
0,13%
Bitcoin
65.206,25
1,89%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AlloVir Inc (ALVR)

  7. AlloVir Inc (ALVR) News

ALVR AlloVir Inc

0,798
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:21:54
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
AlloVir Inc ALVR NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 0,798 10:21:54
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,798
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
14.3.202411:10PRNUSClass Action Filed Against AlloVir, Inc. (ALVR) Seeking..
07.3.202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
22.2.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202411:45PRNUSClass Action Filed Against AlloVir, Inc. (ALVR) Seeking..
22.2.202402:22EDGAR2Form 144 - Report of proposed sale of securities
20.2.202423:00EDGAR2Form 144 - Report of proposed sale of securities
15.2.202422:30EDGAR2Form RW - Registration Withdrawal Request
12.2.202422:34EDGAR2Form 8-K - Current report
09.2.202411:45PRNUSShareholders that lost money on AlloVir, Inc.(ALVR) Urged to..
06.2.202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202402:00EDGAR2Form 144 - Report of proposed sale of securities
02.2.202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26.1.202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
25.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202402:30EDGAR2Form 144 - Report of proposed sale of securities
09.1.202418:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.1.202418:29EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202412:14IHMARKETNEWSWall Street Highlights: Google Rejects Union Negotiations,..
05.1.202400:00EDGAR2Form 144 - Report of proposed sale of securities
04.1.202423:21EDGAR2Form 8-K - Current report
22.12.202313:07EDGAR2Form 8-K - Current report
22.12.202313:00GLOBEAlloVir Provides Updates on Phase 3 Clinical Development..
21.11.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202323:00EDGAR2Form 144 - Report of proposed sale of securities
17.11.202323:30EDGAR2Form 144 - Report of proposed sale of securities
16.11.202313:00BWAlloVir to Present at the Piper Sandler 35th Annual..
02.11.202321:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202313:11EDGAR2Form 8-K - Current report
02.11.202312:00BWAlloVir Reports Third Quarter 2023 Financial Results
23.10.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.10.202323:00EDGAR2Form 144 - Report of proposed sale of securities
05.10.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202323:49EDGAR2Form 144 - Report of proposed sale of securities
28.8.202313:00BWAlloVir to Present at Upcoming Investor Conferences
21.8.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.8.202323:00EDGAR2Form 144 - Report of proposed sale of securities
17.8.202323:07EDGAR2Form 144 - Report of proposed sale of securities
03.8.202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202313:34EDGAR2Form 8-K - Current report
03.8.202313:00BWAlloVir Reports Second Quarter 2023 Financial Results
21.7.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.7.202301:23EDGAR2Form 144 - Report of proposed sale of securities
12.7.202313:41IHMARKETNEWSWednesday’s Wall Street Highlights: Nvidia, VMware,..
06.7.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:49EDGAR2Form 144 - Report of proposed sale of securities
05.7.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.6.202303:20BWAlloVir Announces Pricing of Public Offering of Common Stock
21.6.202322:18BWAlloVir Announces Proposed Public Offering of Common Stock
05.6.202313:00BWAlloVir Presents Positive Final Results From A Phase 2..

Kürzlich von Ihnen besucht

NASDAQ
ALVR
AlloVir
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten